Page-2 of Pharma sector
DTAB suggests one-time licensing for drugs
The Drugs Technical Advisory Board (DTAB) recently recommended one-time licensing for manufacture and sales of drugs. If the recommendation is approved it will change present of the renewal of licences for each formulation which rests with state regulators and takes ..
Month: Current Affairs - December, 2016
Delhi High Court reverses ban on fixed dose combination drugs
The Delhi High Court has quashed ban imposed on 344 fixed dose combination (FDC) drugs by the Central Government over fears that they are potential health and safety hazards. The HC held that Centre had acted in a haphazard manner ..
Month: Current Affairs - December, 2016
WHO settles India, EU medicine dispute issue
The World Health Organisation (WHO) has dropped the term ‘counterfeit’ and retained ‘falsified’ to describe medicines of inferior quality. This decision was taken by a WHO’s technical working group on draft working definitions of substandard/spurious /falsely-labelled/falsified/counterfeit (SSFFC) medical products. It ..
Month: Current Affairs - November, 2016
Indian Pharma companies rank 19th in Biopharmaceutical Competitiveness & Investment (BCI) Survey
Indian pharmaceutical companies have ranked low at 19th position with an overall score of 59 out of 100 among in the Biopharmaceutical Competitiveness & Investment (BCI) Survey. The survey of 28 countries was commissioned by the Pharmaceutical Research and Manufacturers ..
Month: Current Affairs - October, 2016
India seeks greater Pharma market access in Japan
India is seeking greater market access for the domestic pharmaceuticals sector in the Japanese market as India’s share in the Japanese drug market continued to be below par. It was announced by Union Commerce Minister Nirmala Sitharaman in seminar on ..
Month: Current Affairs - October, 2016
Union Government caps prices of 24 essential drugs
The Union Government has capped the prices of 24 essential drugs used for treatment of cancer, HIV, bacterial infections, anxiety and cardiac conditions. In this regard, the Drug pricing regulator National Pharmaceutical Pricing Authority (NPPA) has issued an order. It ..
Month: Current Affairs - August, 2016
Canada to conduct world's first Zika vaccine test on humans
Researchers from Laval University based in Quebec City, Canada are going to conduct the world’s first Zika vaccine test on humans. They are first international researchers team in the world to complete all of the steps in the regulatory process ..
Month: Current Affairs - July, 2016
NPPA fixes ceiling price of 54 drug formulations
The National Pharmaceutical Pricing Authority (NPPA) has fixed ceiling price of 54 drug formulations used for treatment of cancer, bacterial infections, diabetes and hypertension. NPPA has revised/fixed the ceiling prices as per the Schedule-I under Drugs (Price Control) Amendment Order ..
Month: Current Affairs - May, 2016